Literature DB >> 26876981

Role of endoscopic surgery in the management of sinonasal and skull base schwannomas.

Apostolos Karligkiotis1,2,3, Mario Turri-Zanoni2,3, Eleonora Sica2, Carla Facco4, Stefania Freguia4, Anna Mercuri5, Andrea Pistochini2, Maurizio Bignami2,3, Paolo Castelnuovo2,3.   

Abstract

BACKGROUND: The purpose of this study was to report our experience with the endoscopic management of sinonasal schwannomas, analyzing the advantages, limitations, and outcomes of the technique.
METHODS: A retrospective analysis was carried out on 11 patients treated endoscopically between 2000 and 2014 at a single institution.
RESULTS: Eight patients underwent an exclusive endoscopic endonasal approach, whereas, in 3 patients, an osteoplastic flap was combined because of massive or lateral frontal sinus involvement. The tumor extended into the orbit in 5 cases, and involved the skull base in 5 patients who required a concomitant endoscopic duraplasty. No evidence of disease was observed in 10 patients after a mean follow-up of 90.1 months (range, 14-189 months). One patient was alive with persistence of disease, although asymptomatic.
CONCLUSION: The endoscopic endonasal approach is a valid alternative for the vast majority of sinonasal schwannomas with minimal morbidity for the patient.
© 2016 Wiley Periodicals, Inc. Head Neck 38: E2074-E2082, 2016. © 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  endoscopic endonasal approach; frontal sinus; orbit; pterygopalatine fossa; schwannoma; sinonasal benign tumors; skull base

Mesh:

Year:  2016        PMID: 26876981     DOI: 10.1002/hed.24383

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  2 in total

1.  Endoscopic endonasal approach for trigeminal schwannomas: our experience of 39 patients in 10 years.

Authors:  Lu Yang; Li Hu; Weidong Zhao; Huankang Zhang; Quan Liu; Dehui Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-01-19       Impact factor: 2.503

2.  Endoscopic endonasal approach for mass resection of the pterygopalatine fossa.

Authors:  Jan Plzák; Vít Kratochvil; Adam Kešner; Pavol Šurda; Aleš Vlasák; Eduard Zvěřina
Journal:  Clinics (Sao Paulo)       Date:  2017-10       Impact factor: 2.365

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.